# Quokkaboard (쿼카보드)

> Non-commercial public-health education project, built and operated with Claude. Free to read, no ads, no product sales. It turns officially approved medication information (Korea MFDS drug labels, pharmacist drug guides) into plain-Korean health content and publishes it every day across five channels. Channels run under the name InfoMedi (인포메디).

## What it does
- One topic becomes a Naver Blog article, Instagram card news (10 slides), a Threads post, a one-minute Naver Clip video and a YouTube Short.
- Daily output: up to 5 blog articles, 3 card news, 4 Threads posts, up to 8 clips, 4 Shorts.
- As of 2026-10-09: 89 blog articles published, 44 Naver Clip videos, 169 card news sets produced; 1,795 views across all channels on 2026-10-07.

## How Claude is used (from usage records and git history, 2026-10-08)
- 3,481 automated Claude calls in production since 2026-09-23 (2,900 in the last 7 days); about 77M tokens processed (61M input, 16M output).
- 529 of 559 commits across 5 repositories are co-authored with Claude Code. The dashboard, publishing automation, video renderer and website were written by Claude Code, which also deploys them and runs daily server checks.
- Writer: Claude Opus 5.5 reads live search results and official labels, picks the main search intent and writes the article as schema-validated JSON (headless `claude -p --json-schema`).
- Fact-checker: a full review and a risk-item pass (dosing, contraindications, side-effect frequency) run in parallel. A finding counts only with verbatim quotes from the article and the source; Claude fixes the sentence and re-checks it. Nothing publishes until it passes.
- Vision judge: Claude opens every generated illustration to check anatomy, stray text and whether the scene shows the spoken action. For image-to-video scenes it screens frames every 0.5 s for flicker or melting.
- Scriptwriter and director: picks the video format, writes dialogue, scene descriptions and motion prompts for the image-to-video model.
- Social editor: channel-specific card news copy and Threads posts from the same checked article.
- On-call engineer: reads failure logs with read-only tools, writes a root-cause note, retries, flags a human, or proposes a code fix that must pass the full test suite.
- Cost control: a usage ledger routes selected jobs to Claude API credits first and falls back to the Claude subscription automatically when the API stops.

## Accuracy (job records, 2026-10-09)
- 114 drafts fact-checked before publishing; 105 wrong or overstated sentences caught; 104 fixed by Claude and re-checked before going live; 1 held.
- 64 already-published articles updated in place after re-checks.
- Fact-check rule changes are scored against an independent answer key written by a different model (3 runs per change).

## Operations dashboard (screenshots on the site, October 9, 2026)
- Private, password-protected dashboard (it can publish), shown as screenshots at https://quokkaboard.com/#dashboard.
- Home: today's schedule across five channels, search-slot coverage, days of content queued.
- Writing queue: each Claude-written article with its fact-check result; only drafts that pass are scheduled on Naver.
- Naver Clip: short videos scripted, fact-checked and art-directed by Claude, queued into daily upload slots.
- All views: hourly view counts for every piece on every channel, rolled up per day.
- Search map: where our posts and clips appear on Naver mobile search, per keyword.
- Operations: throughput and failures; Claude reads failure logs and writes root-cause notes.

## Principles
- Public purpose: health literacy. No advertising revenue, no product sales, no sponsored content.
- Facts only from approved labels and pharmacist guides; plain words; no promised results; content is general information, not medical advice.

## About
- Company: Quokkaboard (쿼카보드); channels run as InfoMedi (인포메디). Founder: Woojin Lim. Founded September 2026, South Korea. Non-commercial (no ads, no product sales).
- Timeline: 2026-09-23 first Instagram card news and Claude in production; 2026-09-25 first Naver Blog article; 2026-09-29 first Naver Clip video; 2026-10-01 Threads; 2026-10-06 pharmacy-dialogue videos and YouTube Shorts; 2026-10-08 quokkaboard.com, company email, image-to-video motion.

## Contact
- contact@quokkaboard.com
- Blog: https://blog.naver.com/info_medi_
- Instagram: https://www.instagram.com/info_medi_c/
- Threads: https://www.threads.com/@info_medi_c